Decline in the incidence of invasive pneumococcal disease at a medical center in Taiwan, 2000-2012

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Lai, Chih Cheng ^a   Lin, Sheng Hsiang ^b,c   Liao, Chun Hsing ^d   Sheng, Wang Huei ^e   Hsueh, Po Ren ^e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Incidence; Invasive pneumococcal disease; Serotypes; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

ADULT; BACTEREMIA; CHILD; CLASSIFICATION; EPIDEMIOLOGY; HOSPITAL; HUMAN; INCIDENCE; LONGITUDINAL STUDY; PLEURA EFFUSION; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TAIWAN; UNITED STATES;

ADULT; BACTEREMIA; CHILD; HOSPITALS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; PLEURAL EFFUSION; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TAIWAN; UNITED STATES; VACCINES, CONJUGATE;

EID: 84893685196     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-76     Document Type: Article

References (23)

1. Hausdoff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotype. Lancet Infect Dis 2005, 5:83-93. 10.1016/S1473-3099(05)01280-6, 15680778.
2. Garcia-Vidal C, Ardanuy C, Gudiol C, Cuervo G, Calatayud L, Bodro M, Duarte R, Fernández-Sevilla A, Antonio M, Liñares J, Carratalà J. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in cancer patients. J Infect 2012, 65:521-527. 10.1016/j.jinf.2012.08.015, 22954752.
3. Chen LF, Chen HP, Huang YS, Huang KY, Chou P, Lee CC. Pneumococcal pneumonia and the risk of stroke: a population-based follow-up study. PLoS One 2012, 7:e51452. 10.1371/journal.pone.0051452, 3520842, 23251538.
4. Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R. Changes in the molecular epidemiology of Streptococcus pneumoniae causing meningitis following the introduction of pneumococcal conjugate vaccination in England and Wales. J Clin Microbiol 2013, 51:820-827. 10.1128/JCM.01917-12, 3592052, 23269742.
5. Rueda AM, Serpa JA, Matloobi M, Mushtaq M, Musher DM. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore) 2010, 89:331-336. 10.1097/MD.0b013e3181f2b824, 20827110.
6. Henrichsen J. Six newly recongnized types of Streptococcus pneumoniae. J Clin Microbiol 1995, 33:2759-2762. 228570, 8567920.
7. Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 tto 1999. Clin Diagn Lab Immunol 2002, 9:358-365. 119932, 11874878.
8. Täuber MG, Burroughs M, Niemöller UM, Kuster H, Borschberg U, Tuomanen E. Difference pathophysiology in experiemental meningitis cause- by three strains of Streptococcus pneumoniae. J Infect Dis 1991, 163:806-811. 10.1093/infdis/163.4.806, 1901331.
9. Engelhard D, Pomeranz S, Gallily R, Strauss N, Tuomanen E. Serotpye-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis 1997, 175:979-982. 10.1086/514005, 9086164.
10. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992, 60:111-116. 257510, 1729176.
11. Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal diseases in 5 countires. J Infect Dis 2000, 182:840-847. 10.1086/315760, 10950779.
12. Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH, Phelan M, Facklam RR, Cetron MS, Breiman RF, Kolczak M, Schuchat A. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001, 33:797-805. 10.1086/322623, 11512085.
13. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG. Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285:1729-1735. 10.1001/jama.285.13.1729, 11277827, Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.
14. Stanek RJ, Mufson MA. A 20-year epidemiological study of pneumococcal meningitis. Clin Infect Dis 1999, 28:1265-1272. 10.1086/514777, 10451164.
15. Tsai HY, Chen YH, Liao CH, Lu PL, Huang CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010. Int J Antimicrob Agents 2013, 42:312-316. 10.1016/j.ijantimicag.2013.05.013, 23849332.
16. Liao WH, Lin SH, Lai CC, Tan CK, Liao CH, Huang YT, Wang CY, Hsueh PR. Impact of pneumococcal vaccine on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:489-492. 10.1007/s10096-010-0873-7, 20108017.
17. Hausdroff WP, Byrand J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implication for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000, 30:122-140. 10.1086/313609, 10619741.
18. Scott JA, Hall AJ, Dagan R, Dixon JM, Eykyn SJ, Fenoll A, Hortal M, Jetté LP, Jorgensen JH, Lamothe F, Latorre C, Macfarlane JT, Shlaes DM, Smart LE, Taunay A. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7000 episodes of invasive disease. Clin Infect Dis 1996, 22:973-981. 10.1093/clinids/22.6.973, 8783696.
19. Sniadack DH, Schwartz B, Lipman H, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children-implications for vaccine strategies. Pediatr Infect Dis J 1995, 14:503-510. 10.1097/00006454-199506000-00007, 7667055.
20. Austrian R. The enduring pneumococcus: unfinished business and opportunities for the future. Microb Drug Resist 1997, 3:111-115. 10.1089/mdr.1997.3.111, 9185136.
21. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, Lim WS. Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults. Eur Respir J 2013, 42:733-741. 10.1183/09031936.00144712, 23258784.
22. Liu C, Xiong X, Xu W, Sun J, Wang L, Li J. Serotypes and patterns of anitbiotic resistance in strains causing invasive pneumococcal disease in children less than 5 years of age. PLoS One 2013, 8:e54254. 10.1371/journal.pone.0054254, 3544833, 23342111.
23. Reijtman V, Fossati S, Hernández C, Sommerfleck P, Bernáldez P, Litterio M, Berberian G, Regueira M, Lopardo H. Serotype distribution of pneumococci isolated from pediatric patients with acute otitis media and invasive infection, and potential coverage of pneumococcal conjugated vaccines. Rev Argent Microbiol 2013, 45:27-33.